Nobilus

Nobilus Ent is a Polish biotechnology company dedicated to the development of innovative technologies for the production of plasma-derived and recombinant therapeutic proteins. Based in Kutno, the company specializes in advanced protein purification and isolation processes, aiming to improve the efficiency and accessibility of life-saving treatments. Their portfolio includes the development of biosimilars and proprietary methods for extracting albumin, immunoglobulins, and coagulation factors from human plasma. Nobilus Ent operates a state-of-the-art R&D facility and pilot production line, offering contract development and manufacturing services (CDMO) to international partners. The company's mission is to bridge the gap between high-tech research and large-scale pharmaceutical production through scalable and cost-effective solutions.